Drug-related Overdose Prevention; Revises provisions relating to prescribing, ordering, & dispensing of emergency opioid antagonists; authorizes pharmacists to order certain emergency opioid antagonists; provides specified immunities; authorizes personnel of law enforcement agencies & other agencies to administer emergency opioid antagonists; revises requirements for certain health awareness campaign; requires reporting of controlled substance overdoses.
Laid on Table; companion bill(s) passed, see CS/SB 544 (Ch. 2022-28)
Substituted CS/SB 544
Bill added to Special Order Calendar (2/22/2022)
Reported out of Health & Human Services Committee
Added to Second Reading Calendar
Bill released to House Calendar
Favorable by Health & Human Services Committee
Added to Health & Human Services Committee agenda
Now in Health & Human Services Committee
Referred to Health & Human Services Committee
Original reference removed: Health Care Appropriations Subcommittee
1st Reading (Committee Substitute 1)
CS Filed
Laid on Table under Rule 7.18(a)
Reported out of Professions & Public Health Subcommittee
Favorable with CS by Professions & Public Health Subcommittee
PCS added to Professions & Public Health Subcommittee agenda
Removed from Meeting Agenda of Professions & Public Health Subcommittee
Added to Professions & Public Health Subcommittee agenda
1st Reading (Original Filed Version)
Referred to Professions & Public Health Subcommittee
Now in Professions & Public Health Subcommittee
Referred to Health & Human Services Committee
Referred to Health Care Appropriations Subcommittee
Filed
Bill Text Versions | Format |
---|---|
H 731 Filed | |
H 731 c1 |
Document | Format |
---|---|
Bill Analysis -- Health and Human Services Committee (Post-Meeting) (2/1/2022 2:39 PM) | |
Bill Analysis -- Professions and Public Health Subcommittee (Post-Meeting) (7/7/2022 9:39 AM) |
Data on Open States is updated periodically throughout the day from the official website of the Florida Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.